Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO David Rosa disposed of 2,239 shares of NeuroOne Medical Technologies to cover tax obligations arising from a previous transaction.
Summary
- On May 31, 2024, David A Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 2,239 shares of common stock.
- The shares were disposed of at a price of $0.9299 per share.
- This transaction was to cover tax obligations.
- Following the transaction, Rosa directly owns 1,160,358 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard Form 4 filing, indicating a transaction by an insider. The sentiment is neutral as it simply reports a stock disposal to cover tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The disposal of shares by the CEO could be perceived negatively by some shareholders, although it is stated to be for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: David Rosa disposed of 2,239 shares of NeuroOne Medical Technologies Corp. |
| 06/04/2024 | Date of signature by Power of Attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.